228 related articles for article (PubMed ID: 9011381)
61. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.
Seppälä H; Nissinen A; Yu Q; Huovinen P
J Antimicrob Chemother; 1993 Dec; 32(6):885-91. PubMed ID: 8144429
[No Abstract] [Full Text] [Related]
62. A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
Hua CZ; Yu H; Xu HM; Yang LH; Lin AW; Lyu Q; Lu HP; Xu ZW; Gao W; Chen XJ; Wang CQ; Jing CM
BMC Pediatr; 2019 Jun; 19(1):181. PubMed ID: 31167650
[TBL] [Abstract][Full Text] [Related]
63. [Streptococcus pyogenes/group a streptococcus: an extra-cellular bacteria whose only known reservoir is man].
Raymond J; Haas H; Grimprel E; Cohen R
Arch Pediatr; 2014 Nov; 21 Suppl 2():S51-3. PubMed ID: 25456680
[No Abstract] [Full Text] [Related]
64. Bacteremic infections due to clindamycin-resistant streptococci.
Drapkin MS; Karchmer AW; Moellering RC
JAMA; 1976 Jul; 236(3):263-5. PubMed ID: 778419
[TBL] [Abstract][Full Text] [Related]
65. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci.
Seppälä H; Klaukka T; Lehtonen R; Nenonen E; Huovinen P
Clin Infect Dis; 1995 Dec; 21(6):1378-85. PubMed ID: 8749619
[TBL] [Abstract][Full Text] [Related]
66. Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres.
Holmström L; Nyman B; Rosengren M; Wallander S; Ripa T
Scand J Infect Dis; 1990; 22(2):179-85. PubMed ID: 2113310
[TBL] [Abstract][Full Text] [Related]
67. Opacity factor inhibition test for typing group A beta-haemolytic streptococcus strains and antibiotic susceptibility.
Yang YH; Shen XZ; Totolian A; Beliakova I
Adv Exp Med Biol; 1997; 418():45-7. PubMed ID: 9331595
[No Abstract] [Full Text] [Related]
68. Increasing clindamycin resistance among Australian group B streptococcus isolates.
Chang LW; Garland SM; Daley AJ; Chean R
Intern Med J; 2015 Apr; 45(4):465-6. PubMed ID: 25827518
[No Abstract] [Full Text] [Related]
69. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection.
Vilhonen J; Vuopio J; Vahlberg T; Gröndahl-Yli-Hannuksela K; Rantakokko-Jalava K; Oksi J
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1339-1348. PubMed ID: 32096108
[TBL] [Abstract][Full Text] [Related]
70. Drug resistance in Streptococcus pyogenes isolated in Japan.
Nakae M; Murai T; Kaneko Y; Mitsuhashi S
Antimicrob Agents Chemother; 1977 Sep; 12(3):427-8. PubMed ID: 334068
[TBL] [Abstract][Full Text] [Related]
71. Multi drug resistance in group A hemolytic streptococci in Japan from 1972 to 1977.
Yamada T; Kosakai N
Jpn Circ J; 1980 Oct; 44(10):801-3. PubMed ID: 7001083
[No Abstract] [Full Text] [Related]
72. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
Betriu C; Sanchez A; Gomez M; Cruceyra A; Picazo JJ
Antimicrob Agents Chemother; 1993 Aug; 37(8):1717-9. PubMed ID: 8215292
[TBL] [Abstract][Full Text] [Related]
73. Erythromycin resistant Streptococcus pyogenes in Cambridge.
Walker M; Whetstone RJ; Whipp J
J Infect; 1984 Jan; 8(1):88-9. PubMed ID: 6366072
[No Abstract] [Full Text] [Related]
74. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection.
Zimbelman J; Palmer A; Todd J
Pediatr Infect Dis J; 1999 Dec; 18(12):1096-100. PubMed ID: 10608632
[TBL] [Abstract][Full Text] [Related]
75. [Does the antitoxin activity of clindamycin decrease mortality in invasive streptococcal infections?].
Ferry T
Med Mal Infect; 2015 May; 45(5):185-6. PubMed ID: 26153577
[No Abstract] [Full Text] [Related]
76. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy.
Borzani M; De Luca M; Varotto F
J Antimicrob Chemother; 1997 Sep; 40(3):457-8. PubMed ID: 9338507
[No Abstract] [Full Text] [Related]
77. Streptococcal myositis.
Mulla ZD
Br J Plast Surg; 2003 Jun; 56(4):424. PubMed ID: 12873476
[No Abstract] [Full Text] [Related]
78. Erythromycin resistance in group A streptococci.
Järvinen H; Nissinen A; Huovinen P
Lancet; 1989 May; 1(8645):1022-3. PubMed ID: 2565500
[No Abstract] [Full Text] [Related]
79. [Antibiotic resistance to Streptococcus pyogenes: what's happening?].
Colomina Rodríguez J; Villar Serrano J; Burgos Teruel A; Guerrero Espejo A
Rev Clin Esp; 2004 Dec; 204(12):661. PubMed ID: 15710078
[No Abstract] [Full Text] [Related]
80. Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?
Panagea S; Perry JD; Gould FK
J Antimicrob Chemother; 1999 Oct; 44(4):581-2. PubMed ID: 10588329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
